Literature DB >> 26290382

PDGFRβ and oncogenic mutant PDGFRα D842V promote disassembly of primary cilia through a PLCγ- and AURKA-dependent mechanism.

Brian S Nielsen1, Raj R Malinda1, Fabian M Schmid1, Stine F Pedersen1, Søren T Christensen1, Lotte B Pedersen2.   

Abstract

Primary cilia are microtubule-based sensory organelles projecting from most quiescent mammalian cells, which disassemble in cells cultured in serum-deprived conditions upon re-addition of serum or growth factors. Platelet-derived growth factors (PDGF) are implicated in deciliation, but the specific receptor isoforms and mechanisms involved are unclear. We report that PDGFRβ promotes deciliation in cultured cells and provide evidence implicating PLCγ and intracellular Ca(2+) release in this process. Activation of wild-type PDGFRα alone did not elicit deciliation. However, expression of constitutively active PDGFRα D842V mutant receptor, which potently activates PLCγ (also known as PLCG1), caused significant deciliation, and this phenotype was rescued by inhibiting PDGFRα D842V kinase activity or AURKA. We propose that PDGFRβ and PDGFRα D842V promote deciliation through PLCγ-mediated Ca(2+) release from intracellular stores, causing activation of calmodulin and AURKA-triggered deciliation.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Aurora A kinase; Deciliation; Gastrointestinal stromal tumor; PLCγ; Platelet-derived growth factor receptor; Primary cilia

Mesh:

Substances:

Year:  2015        PMID: 26290382     DOI: 10.1242/jcs.173559

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  17 in total

Review 1.  Cilium assembly and disassembly.

Authors:  Irma Sánchez; Brian David Dynlacht
Journal:  Nat Cell Biol       Date:  2016-06-28       Impact factor: 28.824

Review 2.  Primary Cilia and Coordination of Receptor Tyrosine Kinase (RTK) and Transforming Growth Factor β (TGF-β) Signaling.

Authors:  Søren T Christensen; Stine K Morthorst; Johanne B Mogensen; Lotte B Pedersen
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

Review 3.  Cellular signalling by primary cilia in development, organ function and disease.

Authors:  Zeinab Anvarian; Kirk Mykytyn; Saikat Mukhopadhyay; Lotte Bang Pedersen; Søren Tvorup Christensen
Journal:  Nat Rev Nephrol       Date:  2019-04       Impact factor: 28.314

Review 4.  Ciliary signalling in cancer.

Authors:  Hanqing Liu; Anna A Kiseleva; Erica A Golemis
Journal:  Nat Rev Cancer       Date:  2018-08       Impact factor: 60.716

5.  A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.

Authors:  S E Conduit; V Ramaswamy; M Remke; D N Watkins; B J Wainwright; M D Taylor; C A Mitchell; J M Dyson
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

Review 6.  Mechanisms for nonmitotic activation of Aurora-A at cilia.

Authors:  Vladislav Korobeynikov; Alexander Y Deneka; Erica A Golemis
Journal:  Biochem Soc Trans       Date:  2017-02-08       Impact factor: 5.407

Review 7.  Mechanism and Regulation of Centriole and Cilium Biogenesis.

Authors:  David K Breslow; Andrew J Holland
Journal:  Annu Rev Biochem       Date:  2019-01-11       Impact factor: 23.643

Review 8.  The regulation of cilium assembly and disassembly in development and disease.

Authors:  Lei Wang; Brian D Dynlacht
Journal:  Development       Date:  2018-09-17       Impact factor: 6.868

9.  IFT20 modulates ciliary PDGFRα signaling by regulating the stability of Cbl E3 ubiquitin ligases.

Authors:  Fabian Marc Schmid; Kenneth Bødtker Schou; Martin Juel Vilhelm; Maria Schrøder Holm; Loretta Breslin; Pietro Farinelli; Lars Allan Larsen; Jens Skorstengaard Andersen; Lotte Bang Pedersen; Søren Tvorup Christensen
Journal:  J Cell Biol       Date:  2017-12-13       Impact factor: 10.539

10.  Cyclic expression of the voltage-gated potassium channel KV10.1 promotes disassembly of the primary cilium.

Authors:  Araceli Sánchez; Diana Urrego; Luis A Pardo
Journal:  EMBO Rep       Date:  2016-04-20       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.